{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T09:57:58Z","timestamp":1775815078460,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"11","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.bcp.2013.09.012","type":"journal-article","created":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T01:30:33Z","timestamp":1379899833000},"page":"1576-1583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The role of mutant protein level in autosomal recessive catecholamine dependent polymorphic ventricular tachycardia (CPVT2)"],"prefix":"10.1016","volume":"86","author":[{"given":"Guy","family":"Katz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asher","family":"Shainberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Hochhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efrat","family":"Kurtzwald-Josefson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahuva","family":"Issac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"El-Ani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Aravot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon","family":"Afek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan G.","family":"Seidman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine E.","family":"Seidman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Eldar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Arad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2013.09.012_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cpcardiol.2008.09.002","article-title":"Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond","volume":"34","author":"Katz","year":"2009","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0010","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/CIRCRESAHA.110.226845","article-title":"Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis","volume":"108","author":"Priori","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2013.09.012_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2013.09.012_bib0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1050-1738(03)00025-2","article-title":"A missense mutation in the CASQ2 gene is associated with autosomal-recessive catecholamine-induced polymorphic ventricular tachycardia","volume":"13","author":"Eldar","year":"2003","journal-title":"Trends Cardiovascul Med"},{"key":"10.1016\/j.bcp.2013.09.012_bib0025","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1086\/324565","article-title":"A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel","volume":"69","author":"Lahat","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bcp.2013.09.012_bib0030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation\u2013contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2013.09.012_bib0035","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1161\/01.CIR.103.23.2822","article-title":"Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p 13\u201321","volume":"103","author":"Lahat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2013.09.012_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.RES.0000038886.18992.6B","article-title":"Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia","volume":"91","author":"Postma","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2013.09.012_bib0045","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.hrthm.2010.07.004","article-title":"Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice","volume":"7","author":"Katz","year":"2010","journal-title":"Heart Rhythms"},{"key":"10.1016\/j.bcp.2013.09.012_bib0050","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1172\/JCI31080","article-title":"Increased calreticulin and ryanodine receptors by calsequestrin-2 (CASQ2) mutations cause catecholaminergic polymorphic ventricular tachycardia","volume":"117","author":"Song","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2013.09.012_bib0055","first-page":"2510","article-title":"Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia","volume":"116","author":"Knollmann","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2013.09.012_bib0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/bj20021771","article-title":"Effects of prenatal glucocorticoid exposure on cardiac calreticulin and calsequestrin protein expression during early development and in adulthood","volume":"371","author":"Langdown","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2013.09.012_bib0065","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1006\/jmcc.2001.1387","article-title":"Activation of A(3)adenosine receptor protects against doxorubicin-induced cardiotoxicity","volume":"33","author":"Shneyvays","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-2952(97)00108-1","article-title":"Inhibition of calcium accumulation by the sarcoplasmic reticulum: a putative mechanism for the cardiotoxicity of adriamycin","volume":"54","author":"Halili-Rutman","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0143-4160(02)00056-8","article-title":"Differential aspects in ratio measurements of [Ca2+]i relaxation in cardiomyocyte contraction following various drug treatments","volume":"31","author":"Fixler","year":"2002","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bcp.2013.09.012_bib0080","doi-asserted-by":"crossref","first-page":"21400","DOI":"10.1074\/jbc.M411952200","article-title":"NF-kappaB and not the MAPK signaling pathway regulates GADD45beta expression during acute inflammation","volume":"280","author":"Zhang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2013.09.012_bib0085","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1152\/ajplung.00035.2008","article-title":"Proteasome inhibition improves diaphragm function in congestive heart failure rats","volume":"294","author":"van Hees","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0090","first-page":"265","article-title":"Intralumenal sarcoplasmic reticulum Ca(2+)-binding proteins","volume":"1","author":"Cala","year":"1990","journal-title":"Semin Cell Biol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pbiomolbio.2003.07.001","article-title":"Calsequestrin and the calcium release channel of skeletal and cardiac muscle","volume":"85","author":"Beard","year":"2004","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj3010465","article-title":"Calsequestrin is a component of smooth muscles: the skeletal- and cardiac-muscle isoforms are both present, although in highly variable amounts and ratios","volume":"301","author":"Volpe","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2013.09.012_bib0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCRESAHA.108.171660","article-title":"Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model","volume":"103","author":"Rizzi","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2013.09.012_bib0110","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.E07-05-0487","article-title":"Regulation of ubiquitin\u2013proteasome system mediated degradation by cytosolic stress","volume":"18","author":"Kelly","year":"2007","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bcp.2013.09.012_bib0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0167-7799(94)90082-5","article-title":"Off-pathway aggregation of proteins","volume":"12","author":"Mutations","year":"1994","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0120","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0006-291X(03)00809-X","article-title":"Selective degradation of oxidatively modified protein substrates by the proteasome","volume":"305","author":"Grune","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2013.09.012_bib0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cardiores.2005.01.004","article-title":"Impairment of the ubiquitin\u2013proteasome system by truncated cardiac myosin binding protein C mutants","volume":"66","author":"Sarikas","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bcp.2013.09.012_bib0130","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","article-title":"Aggresomes, inclusion bodies and protein aggregation","volume":"10","author":"Kopito","year":"2000","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0135","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00062.2006","article-title":"The ubiquitin\u2013proteasome system in cardiac physiology and pathology","volume":"291","author":"Powell","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yjmcc.2008.03.025","article-title":"Protein quality control and degradation in cardiomyocytes","volume":"45","author":"Wang","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0145","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCULATIONAHA.106.649863","article-title":"The bitter end: the ubiquitin\u2013proteasome system and cardiac dysfunction","volume":"115","author":"Patterson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2013.09.012_bib0150","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/cvr\/cvn128","article-title":"Over-expression of endoplasmic reticulum-resident chaperone attenuates cardiomyocyte death induced by proteasome inhibition","volume":"79","author":"Fu","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bcp.2013.09.012_bib0155","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.RES.0000239412.40685.61","article-title":"The cardiac 26S proteasome: regulating the regulator","volume":"99","author":"Powell","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2013.09.012_bib0160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature07962","article-title":"The ubiquitylation machinery of the endoplasmic reticulum","volume":"458","author":"Hirsch","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2013.09.012_bib0165","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0024-3205(02)01826-X","article-title":"Developmental changes of Ca2+ handling in mouse ventricular cells from early embryo to adulthood","volume":"71","author":"Liu","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2013.09.012_bib0170","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1113\/jphysiol.2010.189670","article-title":"Postnatal development of mouse heart: formation of energetic microdomains","volume":"588","author":"Piquereau","year":"2010","journal-title":"J Physiol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2407-6-129","article-title":"Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report","volume":"6","author":"Voortman","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2013.09.012_bib0180","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2141.2007.06659.x","article-title":"Unexpected cardiotoxicity in haematological bortezomib treated patients","volume":"138","author":"Enrico","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0185","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12185-008-0139-7","article-title":"Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib","volume":"88","author":"Hacihanefioglu","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0190","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1152\/ajpheart.00328.2005","article-title":"Proteasome degradation of GRK2 during ischemia and ventricular tachyarrhythmias in a canine model of myocardial infarction","volume":"289","author":"Yu","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1469-7793.1999.0005z.x","article-title":"G-protein coupled receptor kinases as modulators of G-protein signalling","volume":"517","author":"Bunemann","year":"1999","journal-title":"J Physiol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.fjc.0000151930.12026.b7","article-title":"Tumor necrosis factor alpha, rapid ventricular tachyarrhythmias, and infarct size in canine models of myocardial infarction","volume":"45","author":"Yu","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.bcp.2013.09.012_bib0205","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1161\/01.CIR.102.20.2535","article-title":"Ischemic inactivation of G protein-coupled receptor kinase and altered desensitization of canine cardiac beta-adrenergic receptors","volume":"102","author":"Yu","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2013.09.012_bib0210","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2146\/ajhp070272","article-title":"Bortezomib: a novel chemotherapeutic agent for hematologic malignancies","volume":"65","author":"Utecht","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.bcp.2013.09.012_bib0215","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia","volume":"358","author":"Wilde","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295213006023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295213006023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T15:52:19Z","timestamp":1539359539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295213006023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0006295213006023"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2013.09.012","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of mutant protein level in autosomal recessive catecholamine dependent polymorphic ventricular tachycardia (CPVT2)","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2013.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}